Physician profile
Lawrence Kim
NPI 1063779171
$790.23
in general payments reported to CMS, 2019-2025
11 companies · $83.58 in 2025
The $83.58 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $27.97 · 2021: $91.21 · 2022: $141 · 2023: $162 · 2024: $82.06 · 2025: $83.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $395.66 | 2019-2024 | Nucala |
| Abiomed | $124.51 | 2023 | Impella |
| Pfizer INC. | $50.24 | 2025 | |
| Kestra Medical Technology Services, INC. | $49.38 | 2024 | Assure Wcd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.61 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.34 | 2025 | Lifevest |
| Insmed, INC. | $23.52 | 2019 | |
| Mylan Specialty L.P. | $20.70 | 2019 | |
| Monaghan Medical Corporation | $18.80 | 2023 | Aerobika |
| Bayer Healthcare Pharmaceuticals INC. | $18.34 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $18.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.